Joanna Tober

Joanna Tober

Auto-generated profile, based on publicly available information

Joanna Tober

Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, PA 19104, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2020 in Blood
Verified
Journal Article
Open access
PDF file
QZQin Zhu
Qin Zhu
PGPeng Gao
Peng Gao
JTJoanna Tober
Joanna Tober
LBLaura Bennett
Laura Bennett
CCChangya Chen
Changya Chen
KTKai Tan
Kai Tan
Hematopoietic stem and progenitor cells (HSPCs) in the bone marrow are derived from a small population of hemogenic endothelial (HE) cells located in the major arteries of the mammalian embryo. HE cells undergo an endothelial to hematopoietic cell transition, giving rise to HSPCs that accumulate in intra-arterial clusters (IAC) before colonizing the fetal liver. To examine the cell and molecular transitions between endothelial (E), HE, and IAC cells, and the heterogeneity of HSPCs within IACs, we profiled ∼40 000 cells from the caudal arteries (dorsal aorta, umbilical, vitelline) of 9.5 days post coitus (dpc) to 11.5 dpc mouse embryos by single-cell RNA sequencing and single-cell assay for transposase-accessible chromatin sequencing. We identified a continuous developmental trajectory from E to HE to IAC cells, with identifiable intermediate stages. The intermediate stage most proximal to HE, which we term pre-HE, is characterized by increased accessibility of chromatin enriched for SOX, FOX, GATA, and SMAD motifs. A developmental bottleneck separates pre-HE from HE, with RUNX1 dosage regulating the efficiency of the pre-HE to HE transition. A distal candidate Runx1 enhancer exhibits high chromatin accessibility specifically in pre-HE cells at the bottleneck, but loses accessibility thereafter. Distinct developmental trajectories within IAC cells result in 2 populations of CD45+ HSPCs; an initial wave of lymphomyeloid-biased progenitors, followed by precursors of hematopoietic stem cells (pre-HSCs). This multiomics single-cell atlas significantly expands our understanding of pre-HSC ontogeny.

27 December 2017 in Journal of Experimental Medicine
Verified
Journal Article
Open access
JTJoanna Tober
Joanna Tober
MMMarijke M.W. Maijenburg
Marijke M.W. Maijenburg
YLYan Li
Yan Li
LGLong Gao
Long Gao
BHBrandon K. Hadland
Brandon K. Hadland
NSNancy A. Speck
Nancy A. Speck
Hematopoietic stem cells (HSCs) mature from pre-HSCs that originate in the major arteries of the embryo. To identify HSCs from in vitro sources, it will be necessary to refine markers of HSCs matured ex vivo. We purified and compared the transcriptomes of pre-HSCs, HSCs matured ex vivo, and fetal liver HSCs. We found that HSC maturation in vivo or ex vivo is accompanied by the down-regulation of genes involved in embryonic development and vasculogenesis, and up-regulation of genes involved in hematopoietic organ development, lymphoid development, and immune responses. Ex vivo matured HSCs more closely resemble fetal liver HSCs than pre-HSCs, but are not their molecular equivalents. We show that ex vivo–matured and fetal liver HSCs express programmed death ligand 1 (PD-L1). PD-L1 does not mark all pre-HSCs, but cell surface PD-L1 was present on HSCs matured ex vivo. PD-L1 signaling is not required for engraftment of embryonic HSCs. Hence, up-regulation of PD-L1 is a correlate of, but not a requirement for, HSC maturation.

11 June 2026 in Experimental Hematology
Verified
Journal Article
Open access
XJXinjun Ji
Xinjun Ji
JTJoanna Tober
Joanna Tober
SLStephen A. Liebhaber
Stephen A. Liebhaber
NSNancy A. Speck
Nancy A. Speck
Two paralogous RNA-binding proteins, PCBP1 and PCBP2, are individually essential for mouse development; Pcbp2-null embryos lose viability at mid-gestation, while Pcbp1-null embryos have an earlier, peri-implantation lethality. Inactivation of each gene alone in the differentiating erythroid lineage failed to impact embryonic viability, while combined Pcbp1/Pcbp2 inactivation resulted in repression of erythroid/hematopoietic gene expression mid-gestation, decreased blood cell formation, and fetal demise. Here, we assess the impacts of individual and combined conditional inactivation of Pcbp1 and Pcbp2 in endothelial cells on embryonic hematopoietic stem and progenitor cell (HSPC) formation. Inactivation of Pcbp1 in endothelial cells is embryonic lethal and reduces the number of HSPCs, while loss of Pcbp2 has no impact. Combined deletion of Pcbp1 and Pcbp2 in endothelial cells results in a more severe phenotype than loss of Pcbp1 alone, demonstrating that although Pcbp1 is a major regulator of HSPC formation, the two genes have non-redundant roles in endothelial cells. TEASER RNA-binding proteins, PCBP1 and PCBP2, are individually essential for mouse development and erythropoiesis/hematopoiesis. In this report, we assess the impacts of individual and combined conditional inactivation of Pcbp1 and Pcbp2 in endothelial cells on embryonic hematopoietic stem and progenitor cell (HSPC) formation. Inactivation of Pcbp1 in endothelial cells is embryonic lethal and reduces the number of HSPCs, while loss of Pcbp2 has no impact. Combined deletion of Pcbp1 and Pcbp2 in endothelial cells results in a more severe phenotype than loss of Pcbp1 alone, demonstrating that although Pcbp1 is a major regulator of HSPC formation, the two genes have non-redundant roles in endothelial cells.

24 July 2026 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MRMelissa M. Rowe
Melissa M. Rowe
JTJoanna Tober
Joanna Tober
VOVivian Ortiz
Vivian Ortiz
RSRiham Smoom
Riham Smoom
YTYehuda Tzfati
Yehuda Tzfati
KKKlaus H Kaestner
Klaus H Kaestner